A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer

Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally advanced, recurrent, or metastatic pancreatic adenocarcinoma were assessed fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Han, Boram, Kim, Bum Jun, Kim, Hyeong Su, Choi, Dae Ro, Shim, Byoung Yong, Lee, Kyung Hee, Kim, Jin Won, Kim, Jung Han, Song, Hunho, Kim, Jong Hyeok, Park, Choong Kee, Lee, Jung Woo, Kim, Min-Jeong, Zang, Dae Young
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2021
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778528/
https://ncbi.nlm.nih.gov/pubmed/33403047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.50514
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados